News | March 08, 2010

Optimizing PCI Outcomes, Evolving Paradigms Covered at ACC

March 5, 2010 – Experts will lead an evening symposium during ACC 2010 that will cover the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease. Those attending will be exposed to the latest clinical trial data on current and second-generation drug-eluting stent therapies.

The event is from 5–9:10 p.m. Saturday, March 13 at the Omni Hotel, 100 CNN Center, Atlanta.

The session includes both didactic and case-based presentations. Attendees will be exposed to the latest clinical and evidence-based medicine options to optimize patient outcomes in the treatment of coronary artery disease.

The program is sponsored by the Cardiovascular Research Foundation (CRF). This event is not part of the official ACC Annual Scientific Session or the i2 Summit.

For more information: www.pcioutcomes.com/register.html


Additional Content

News | Stents

Nov. 24, 2025 — InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke ...

Home November 24, 2025
Home
News | Stents

Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...

Home October 13, 2025
Home
News | Stents

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...

Home October 16, 2024
Home
News | Stents

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
News | Stents

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
Subscribe Now